RESUMO
Formaldehyde adsorption on intrinsic La2O3 surface, four-fold coordinated oxygen vacancy (VO4c), six-fold coordinated oxygen vacancy (VO6c), and iridium-doped La2O3(001) surface was studied by the first-principles method. The results show that formaldehyde adsorption on the Ir-doped La2O3(001) surface with VO6c is the strongest because of the directional movement of electrons caused by the interaction of the Ir-5d orbitals and internal oxygen vacancy, wherein the adsorption energy is 3.23 eV. This model showed a significant increase in adsorption energy, indicating that Ir doping improves the formaldehyde adsorption capacity of the La2O3(001) surface. The energy band analysis shows that iridium doping introduces impurity energy levels into the intrinsic La2O3 energy band, which enhances the interaction between the La2O3(001) surface and formaldehyde molecules. Density of state analysis indicated that the adsorption of formaldehyde molecules on the La2O3(001) surface is mainly due to the interaction between the O-2p, C-2p orbitals of formaldehyde and the Ir-5d orbital of iridium atoms. Furthermore, the existence of VO4c and VO6c defects has no effect on the position and shape of the valence and conduction bands. The effects of oxygen vacancy and iridium doping on the optical properties mainly appeared in the low-energy infrared and visible regions, making the O-2p, C-2p orbitals of formaldehyde and the Ir-5d, O-2p orbitals of the La2O3(001) surface become hybridized near the Fermi level and the electronic transition from the valence band to conduction band more likely to occur. The La2O3 material can be used as an ideal photocatalytic material for formaldehyde degradation.
RESUMO
Background: Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease that affects approximately one-quarter of the global population and is becoming increasingly prevalent worldwide. The lack of current noninvasive tools and efficient treatment is recognized as a significant barrier to the clinical management of these conditions. Extracellular vesicles (EVs) are nanoscale vesicles released by various cells and deliver bioactive molecules to target cells, thereby mediating various processes, including the development of NAFLD. Scope of review: There is still a long way to actualize the application of EVs in NAFLD diagnosis and treatment. Herein, we summarize the roles of EVs in NAFLD and highlight their prospects for clinical application as a novel noninvasive diagnostic tool as well as a promising therapy for NAFLD, owing to their unique physiochemical characteristics. We summarize the literatures on the mechanisms by which EVs act as mediators of intercellular communication by regulating metabolism, insulin resistance, inflammation, immune response, intestinal microecology, and fibrosis in NAFLD. We also discuss future challenges that must be resolved to improve the therapeutic potential of EVs. Major conclusions: The levels and contents of EVs change dynamically at different stages of diseases and this phenomenon may be exploited for establishing sensitive stage-specific markers. EVs also have high application potential as drug delivery systems with low immunogenicity and high biocompatibility and can be easily engineered. Research on the mechanisms and clinical applications of EVs in NAFLD is in its initial phase and the applicability of EVs in NAFLD diagnosis and treatment is expected to grow with technological progress.